PLRX Q1 2020 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M

Gross Profit

$29M100.0% margin

Operating Income

$11M38.0% margin

Net Income

$11M38.1% margin

EPS (Diluted)

$0.48

QoQ Revenue Growth

-49.3%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$425,000

Balance Sheet

Total Assets

$184M

Total Liabilities

$10M

Stockholders' Equity

$174M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$0	—
Gross Profit	$29M	$0	—
Operating Income	$11M	-$14M	+176.7%
Net Income	$11M	-$14M	+178.6%